Keywords
lung cancer
quality of life
How to Cite
Abstract
Introduction: Pulmonary rehabilitation is a multidisciplinary intervention, which main goals are to lessen respiratory symptoms, augment exercise tolerance and, therefore, enhance health related life quality on patients with chronic pulmonary diseases, such as Lung Cancer. Objective: To establish the relevance of pulmonary rehabilitation, facilitate the construction of rehab programs that are focused on oncology patients, this with the creation of evaluation and intervention algorithms, all of this within the walls of the National Cancer Institute. Materials and methods: Descriptive study of a bibliographic review taking in account resources as: Academic Google, PubMed, Reveu des Maladies and some others. For the online research the keywords were “pulmonary rehabilitation”, “respiratory therapy”, “pulmonary rehabilitation program” and “cardiovascular and pulmonary rehabilitation”, all of them published between 2009 and 2019, written in Spanish, English or French. Based on this research we proposed evaluation and intervention algorithms for lung cancer patients. Results: The insertion of a specialized pulmonary rehabilitation program can be highly significant with the outcomes of patients with Chronic pulmonary. This can be notices on short term by the patient (who retakes activities and reintegrates within his environment) and their family. The program also slows down the progression of the pathology, therefore diminishing sickness and mortality rates. This can be checked out with close monitoring and assessment of the patient. A pulmonary rehabilitation program must come with a full assessment, so we can track down the progression or regression of the patient, bibliography suggests that this assessments should be performed at least once every three months. In this review we present a suggestion for a pulmonary rehabilitation program for three months, within this period of time the patient will have a physical activity program that takes in account cardiovascular activity as much as strength exercise, all of this supervised by an interdisciplinary team; every month the dosage exercise will be adjusted and, at the end of the third month there will be a reevaluation. Conclusions: Pulmonary rehabilitation has proved to be an excellent source for the management of patients with Chronic Pulmonary Diseases, it would be promising to take this new programs into practice.
References
Ries AL, Bauldoff GS, Carlin BW, Casaburi R, Emery CF, Mahler DA, et al. Pulmonary Rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines. Chest 2007;131(5 Suppl):4S-42S. doi: 10.1378/chest.06-2418
Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. DM. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 10. Lyon: International Agency for Research on Cancer; 2010.
Australian Institute of Health and Welfare, Australasian Association of Cancer Registries AA. Cancer in Australia: an overview, 2008 [Internet]. Canberra: Australian Institute of Health and Welfare; 2008. Disponible en: https://www.aihw.gov.au/getmedia/98bf9bd8-4492-4465-9175-7efb886756cb/ca08.pdf.aspx?inline=true
Australian Institute of Health and Welfare, Australasian Association of Cancer Registries AA. Cancer survival in Australia, 2006. Part 1: national summary statistics [Internet]. Canberra: Australian Institute of Health and Welfare; 2006. Disponible en: https://www.aihw.gov.au/getmedia/d6274ca6-74d7-43a9-aa30-f716912bd986/ca06.pdf.aspx?inline=true
Australian Bureau of Statistics. 3303.0 Causes of death, Australia, 2004 [Internet]. Canberra: ABS; 2006. Disponible en: https://www.abs.gov.au/AUSSTATS/abs@.nsf/allprimarymainfeatures/3AA156BFD4C7E1E0CA25729D0010CB69?opendocument
Pujol JL, Quantin X, Chakra M. Cardiorespiratory fitness in patients with advanced non-small cell lung cancer: why is this feature important to evaluate? Can it be improved? J Thorac Oncol. 2009;4(5):565-567. doi: 10.1097/JTO.0b013e3181a0d761
Manterola Carlos D, Zavando Daniela M. Cómo interpretar los “Niveles de Evidencia” en los diferentes escenarios clínicos. Rev. Chil Cir. 2009;61(6):582-295. doi: 10.4067/S0718-40262009000600017
Delgado Guay MO, Parsons HA, Li Z, Palmer LJ, Bruera E. Symptom distress, interventions, and outcomes of intensive care unit cancer patients referred to a palliative care consult team. Cancer. 2009;115(2):437-45. doi: 10.1002/cncr.24017
Montazeri A, Milroy R, Hole D, McEwen J, Gillis C. How quality of life data contributes to our understanding of cancer patients’ experiences? A study of patients with lung cancer. Qual Life Res. 2003;12:157-66. doi: 10.1023/A:1022232624891
Carlsen K, Jensen AB, Jacobsen E, Krasnik M, Johansen C. Psychosocial aspects of lung cancer. Lung Cancer. 2005;47(3):293-300. doi: 10.1016/j.lungcan.2004.08.002
Degner L, Sloan J. Symptom distress in newly diagnosed ambulatory care patients and as a predictor of survival in lung cancer. J Pain Symptom Manage. 1995;10(6):423-31. doi: 10.1016/0885-3924(95)00056-5
Tanaka K, Akechi T, Okuyama T, Nishiwaki Y, Uchitomi Y. Impact of dyspnea, pain, and fatigue on daily life activities in ambulatory patients with advanced lung cancer. J Pain Symptom Manage. 2002; 23(5):417-23. doi: 10.1016/s0885-3924(02)00376-7
O’Driscoll M, Corner J, Bailey C. The experience of breathlessness in lung cancer. Eur J Cancer Care (Engl). 1999;8(1):37-43. doi: 10.1046/j.1365-2354.1999.00129.x
Grutters JP, Joore MA, Wiegman EM, Langendijk JA, de Ruysscher D, Hochstenbag M, et al. Health-related quality of life in patients surviving non-small cell lung cancer. Thorax. 2010; 65(10):903-7. doi: 10.1136/thx.2010.136390.
Jacot W, Colinet B, Bertrand D, Lacombe S, Bozonnat MC, Daurès JP, et al. Quality of life and comorbidity score as prognostic determinants in non-small-cell lung cancer patients. Ann Oncol. 2008;19(8):1458-64. doi: 10.1093/annonc/mdn064.
England R, Maddocks M, Manderson C, Wilcockn A. Factors influencing exercise performance in thoracic cancer. Respir Med. 2012;106(2):294-9. doi: 10.1016/j.rmed.2011.11.002.
Schmitz KH, Holtzman J, Courneya KS, Masse LC, Duval S, Kane R. Controlled physical activity trials in cancer survivors: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2005;14(7):1588-95. doi: 10.1158/1055-9965.EPI-04-0703
Sarna L. Fluctuations in physical function: adults with non-small cell lung cancer. J Adv Nurs. 1993;18(5):714-24. doi: 10.1046/j.1365-2648.1993.18050714.x
Luctkar-Flude M, Groll D, Woodend K, Tranmer J. Fatigue and physical activity in older patients with cancer: a six-month follow-up study. Oncol Nurs Forum. 2009;36(2):194-202. doi: 10.1188/09.ONF.194-202.
Jones LW, Eves ND, Haykowsky M, Freedland SJ, Mackey JR. Exercise intolerance in cancer and the role of exercise therapy to reverse dysfunction. Lancet Oncol. 2009;10(6):598-605. doi: 10.1016/S1470-2045(09)70031-2.
Loganathan RS, Stover DE, Shi W, Venkatraman E. Prevalence of COPD in women compared to men around the time of diagnosis of primary lung cancer. Chest. 2006;129(5):1305-12. doi: 10.1378/chest.129.5.1305
Jones LW. Peak oxygen consumption and long-term all-cause mortality in nonsmall cell lung cancer. Cancer. 2010;116(20):4825-32. doi: 10.1002/cncr.25396
Jones LW, Hornsby WE, Goetzinger A, Forbes LM, Sherrard EL, Quist M, et al. Prognostic significance of functional capacity and exercise behavior in patients with metastatic non-small cell lung cancer. Lung Cancer. 2012;76(2):248-52. doi: 10.1016/j.lungcan.2011.10.009.
Kasymjanova G, Correa JA, Kreisman H. Prognostic value of the six-minute walk in advanced non-small cell lung cancer. J Thorac Oncol. 2009;4(5):602-7. doi: 10.1097/JTO.0b013e31819e77e8
Butterworth J, Mackey D, Wasnick J. Morgan & Mikhail's Clinical Anesthesiology. 6a ed. McGraw-Hill; 2018.
Nakaya N, Saito-Nakaya K, Akechi T, Kuriyama S, Inagaki M, Kikuchi N, et al. Negative psychological aspects and survival in lung cancer patients. Psychooncology. 2008;17(5):466-73. doi: 10.1002/pon.1259
Medical Research Council Committee on Research into Chronic Bronchitis. Questionnaire on respiratory symptoms. Devon: W J Holman; 1966.
Jones P, Miravitlles M, van der Molen T, Kulich K. Beyond FEV₁ in COPD: a review of patient-reported outcomes and their measurement. Int J Chron Obstruct Pulmon Dis. 2012;7:697-709. doi: 10.2147/COPD.S32675.
Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, et al. The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease. N Engl J Med. 2004;350(10):1005-12. doi: 10.1056/NEJMoa021322
Gloeckl R, Marinov B, Pitta F. Practical recommendations for exercise training in patients with COPD. Eur Respir Rev. 2013;22(128):178-86. doi: 10.1183/09059180.00000513.
Tonguino S, Wilches EC. Rehabilitación pulmonar en paciente candidato a trasplante pulmonar; una revisión sistémica. Rev Cienc Salud [Internet]. 2013;11(3):323-332. Disponible en: https://www.redalyc.org/pdf/562/56229183007.pdf
Vogelmeier CF, Criner GJ, Martínez FJ, Anzueto A, Barnes PJ, Bourbeau J, et al. Informe 2017 de la Iniciativa Global para el Diagnóstico, Tratamiento y Prevención de la Enfermedad Pulmonar Obstructiva Crónica: Resumen Ejecutivo de GOLD. Arch Bronconeumol. 2017;53(3):128–149. doi: 10.1016/j.arbres.2017.02.001
Maltais F, Decramer M, Casaburi R, Barreiro E, Burelle Y, Debigaré R, et al. An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2014;189(9):e15-62. doi: 10.1164/rccm.201402-0373ST
Recommandations de la 1re Conférence de consensus en kinésithérapie respiratoire. Ann Kinésithér [Internet]. 1995;22(1):49. Disponible en: https://kinedoc.org/work/kinedoc/f37146f3-1743-43d9-a44d-f07b5acc53da.pdf
Robles PG, Mathur S, Janaudis-Fereira T, Dolmage TE, Goldstein RS, Brooks D. Measurement of Peripheral Muscle Strength in Individuals With Chronic Obstructive Pulmonary Disease. J Cardiopulm Rehabil Prev. 2011;31(1):11-24. doi: 10.1097/HCR.0b013e3181ebf302.
Nyberg A, Saey D, Maltais F. Why and How Limb Muscle Mass and Function Should Be Measured in Patients with Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc. 2015;12(9):1269-77. doi: 10.1513/AnnalsATS.201505-278PS.
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Copyright (c) 2020 Josue Richard Alcantar Correa, Ignacio Andrés Capparelli, Óscar Gerardo Arrieta Rodríguez, Marisol Arroyo Hernández, Coral Leonor Blé Magaña, Zoe Hernández Gracián, Sandra Ortiz Romero, María Fernanda Casares Thomian, Eva Estefanía Reygadas Bautista, Jassiby Lineth Cervantes Peralta, Sandra Sánchez Marín, Adriana Benavides Lara, Yaneth Caviativa Castro